Forte Biosciences, Inc.
6 clinical trials · Sponsor
◉ Watch Forte Biosciences, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study Testing the Safety and Effects of FB102 in Healthy Volunteers (NCT07623057) | Forte Biosciences, Inc. | 2026-06-23 |
| A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata. (NCT07205159) | Forte Biosciences, Inc. | 2025-10-23 |
| Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease (NCT06982963) | Forte Biosciences, Inc. | 2025-08-04 |
| A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo (NCT06905873) | Forte Biosciences, Inc. | 2025-03-25 |
| Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study (NCT04936113) | Forte Biosciences, Inc. | 2021-06-02 |
| Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis (NCT04504279) | Forte Biosciences, Inc. | 2020-10-13 |
Track Forte Biosciences, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.